Selling a life insurance policy with prostate cancer
Typical payout, eligibility, tax treatment, and timeline for patients with prostate cancer.
At a glance
- Typical payout25-55% of face value
- Best fitAggressive forms qualify higher
- Tax treatmentOften tax-free under §101(g)
- Timeline30-60 days to funds
- EligibilityPolicy ≥ $100K, 2+ years old
What patients with prostate cancer should know
For patients diagnosed with prostate cancer, selling an existing life insurance policy can convert an asset that would otherwise be lost (through lapse, surrender, or unaffordable premiums) into immediate cash. Most cancer patients receive substantially more than the policy’s cash surrender value, often 5-15 times more for advanced or terminal cases.
Aggressive forms qualify higher. Stage matters significantly: earlier-stage diagnoses typically result in lower offers because life expectancy projections are longer. Advanced or terminal diagnoses qualify for viatical settlements under IRS §101(g), which are tax-free at the federal level when the patient is certified by a physician.
How payout ranges work
On a $500,000 policy, a patient with prostate cancer might receive between 25 and 55% of the face value, depending on stage, treatment trajectory, age, policy type, and carrier. That’s between $125,000 and $275,000 in cash, often delivered in 30-60 days from acceptance.
What we’d recommend asking
- What’s the difference between a life settlement and a viatical settlement for my diagnosis?
- How will this affect my Medicaid eligibility?
- What documentation does the buyer need from my oncologist?
- Is there a rescission window if I change my mind?
- Are there better alternatives (policy loan, accelerated death benefit rider)?
Related resources
See what your policy is worth.
Thirty seconds to find out. No medical records, no credit check, no cost.